Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1276982 | 0.96 | KMT2A (0.50) | MEN1KMT2AMAPTLMNAHTT | |
| Tepa SCHEMBL11572 | 0.84 | ABCB11 (0.38) | MEN1KMT2ALMNA | |
| SCHEMBL1299737 | 0.74 | MEN1 (0.43) | MEN1KMT2AMAPTLMNAHTT | |
| SCHEMBL6040966 | 0.72 | — | — | |
| SCHEMBL1299741 | 0.72 | FDPS (0.42) | MEN1KMT2AMAPTLMNAHTT | |
| SCHEMBL38651931 | 0.72 | — | — | |
| SCHEMBL8028936 | 0.69 | MAPT (0.46) | MEN1KMT2AMAPTLMNAHTT | |
| SCHEMBL1276983 | 0.69 | MAPT (0.46) | MEN1KMT2AMAPTMMP1MMP3 | |
| Tepa SCHEMBL7918394 | 0.69 | ABCB11 (0.69) | LMNA | |
| SCHEMBL6040973 | 0.69 | MEN1 (0.46) | MEN1KMT2AMAPTLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025064521-A1 | ULTRAFILTRATION / DIAFILTRATION PURIFICATION METHODS | PROFOUNDBIO US CO. (US) | 2025-03-27 | — | — | WO | claimed |
| US-12227501-B2 | 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors | BAYER AKTIENGESELLSCHAFT (DE) | 2025-02-18 | — | — | US | claimed |
| EP-4271159-A1 | PEROVSKITE SOLAR CELL, AND PHOTOVOLTAIC ASSEMBLY | Contemporary Amperex Technology Co., Limited (CN) | 2023-11-01 | — | — | EP | claimed |
| CN-116829565-A | Method for synthesizing organosilicon compounds from halosilanes | 迈图高新材料公司 | 2023-09-29 | — | — | CN | claimed |
| EP-3921317-B1 | 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS | BAYER AG (DE) | 2023-08-02 | — | — | EP | claimed |
| US-20230046077-A1 | 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-02-16 | — | — | US | claimed |
| CN-115041164-A | Method for preparing copper-based acetylene hydrochlorination catalyst by mechanochemical method | 鄂尔多斯市瀚博科技有限公司 | 2022-09-13 | — | — | CN | claimed |
| EP-3971173-A1 | FLUOROLACTONE AND METHOD FOR PRODUCING SAME | Daikin Industries, Ltd. (JP) | 2022-03-23 | — | — | EP | claimed |
| US-20220064139-A1 | FLUOROLACTONE AND METHOD FOR PRODUCING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2022-03-03 | — | — | US | claimed |
| EP-3921317-A1 | 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS | Bayer Aktiengesellschaft (DE) | 2021-12-15 | — | — | EP | claimed |
| US-20070043207-A1 | Novel coupling agent and uses thereof | LUXEMBOURG INDUSTRIES LTD. (IL) | 2007-02-22 | — | — | US | claimed |
| EP-0098408-B1 | CATALYST CONTAINING A PHOSPHINE OXIDE MODIFIER AND PROCESS FOR PRODUCTION OF POLYMERS HAVING INCREASED 1,2-MICROSTRUCTURE | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1986-10-29 | — | — | EP | claimed |
| EP-0098977-B1 | CATALYST SYSTEM CONTAINING AN ANIONIC INITIATOR AND A PHOSPHINE OXIDE MODIFIER AND PROCESS FOR PRODUCTION OF POLYMERS HAVING INCREASED 1,2 MICROSTRUCTURE | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1986-08-27 | — | — | EP | claimed |
| US-4537939-A | ORGANOLITHIUM INITIATOR WITH A TRI-N-HETEROCYCLIC PHOSPHINE OXIDE MODIFIER | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1985-08-27 | — | — | US | claimed |
| US-4530984-A | Using nonpolar solvent and lithium anionic initiator | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1985-07-23 | — | — | US | claimed |
| US-4476240-A | TRI(N-HETEROCYCLIC) PHOSPHINE OXIDE POLYMERIZATION CATALYSTS, 1,3-DIENE POLYMERIZATION | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1984-10-09 | — | — | US | claimed |
| US-4473661-A | Polymerization catalyst system containing organolithium, dialkyl magnesium and/or trialkyl aluminum, and a phosphine oxide | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1984-09-25 | — | — | US | claimed |
| EP-0098977-A1 | Catalyst system containing an anionic initiator and a phosphine oxide modifier and process for production of polymers having increased 1,2 microstructure | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1984-01-25 | — | — | EP | claimed |
| EP-0098408-A2 | Catalyst containing a phosphine oxide modifier and process for production of polymers having increased 1,2-microstructure | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1984-01-18 | — | — | EP | claimed |
| US-4061644-A | FROM A FURAN AND AMMONIA | CIBA-GEIGY CORPORATION (US) | 1977-12-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064139-A1 | FLUOROLACTONE AND METHOD FOR PRODUCING SAME | AFF1, AFF4, AFF2 | MEN1 177/4885KMT2A 2359/4885MAPT 4753/4885 |
| US-20070043207-A1 | Novel coupling agent and uses thereof | PTMS, ANP32A, MBTPS1 | MEN1 1319/4885KMT2A 4392/4885MAPT 3304/4885 |
| US-20230046077-A1 | 3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS | CSNK1A1, CSNK1G1, CSNK1E | MEN1 3195/4885KMT2A 1912/4885MAPT 2232/4885 |
| US-12227501-B2 | 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors | CSNK1A1, CSNK1G1, CSNK1E | MEN1 3195/4885KMT2A 1912/4885MAPT 2232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.